Insider Ownership Of Regencell Bioscience Holdings
While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.
Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.
Our information suggests that insiders own more than half of Regencell Bioscience Holdings Limited. This gives them effective control of the company. So they have a US$430m stake in this US$531m business. It is good to see this level of investment.
Regencell Bioscience Holdings
RGC
Share Price 7 Day 1 Year
31.32 -13.0% 243.8%
Founder recently bought US$886k worth of stock
On the 25th of July, Yat-Gai Au bought around 22k shares on-market at roughly US$39.48 per share. In the last 3 months, they made an even bigger purchase worth US$1.2m. Yat-Gai has been a buyer over the last 12 months, purchasing a net total of US$2.7m worth in shares.
All directors and employees who were previously granted stock options have agreed to a further lock-up undertaking for an additional six months, until July 20, 2023, the second anniversary of the company's initial public offering. Their shares will remain locked up until such date. A form of the lock-up undertaking is attached hereto as Exhibit 99.1.
https://simplywall.st/stocks/us/pharmaceutica...nformation
https://fintel.io/doc/sec-regencell-bioscienc...19361-9498
While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.
Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.
Our information suggests that insiders own more than half of Regencell Bioscience Holdings Limited. This gives them effective control of the company. So they have a US$430m stake in this US$531m business. It is good to see this level of investment.
Regencell Bioscience Holdings
RGC
Share Price 7 Day 1 Year
31.32 -13.0% 243.8%
Founder recently bought US$886k worth of stock
On the 25th of July, Yat-Gai Au bought around 22k shares on-market at roughly US$39.48 per share. In the last 3 months, they made an even bigger purchase worth US$1.2m. Yat-Gai has been a buyer over the last 12 months, purchasing a net total of US$2.7m worth in shares.
All directors and employees who were previously granted stock options have agreed to a further lock-up undertaking for an additional six months, until July 20, 2023, the second anniversary of the company's initial public offering. Their shares will remain locked up until such date. A form of the lock-up undertaking is attached hereto as Exhibit 99.1.
https://simplywall.st/stocks/us/pharmaceutica...nformation
https://fintel.io/doc/sec-regencell-bioscienc...19361-9498
